Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Systemic Par-4 Inhibits Non-Autochthonous Tumor Growth
Abstract
The tumor suppressor protein Par-4 (Prostate apoptosis response-4) is spontaneously secreted by normal and cancer cells. Extracellular Par-4 induces caspase-dependent apoptosis in cancer cell cultures by binding, via its effector SAC domain, to cell surface GRP78 receptor. However, the functional significance of extracellular Par-4/SAC has not been validated in animal models. We show that Par-4/SAC-transgenic mice express systemic Par-4/SAC protein and are resistant to the growth of non-autochthonous tumors. Consistently, secretory Par-4/SAC pro-apoptotic activity can be transferred from these cancer-resistant transgenic mice to cancer-susceptible mice by bone marrow transplantation. Moreover, intravenous injection of recombinant Par-4 or SAC protein inhibits metastasis of cancer cells. Collectively, our findings indicate that extracellular Par-4/SAC is systemically functional in inhibition of tumor growth and metastasis progression, and may merit investigation as a therapy.
Document Type
Article
Publication Date
7-15-2011
Digital Object Identifier (DOI)
https://doi.org/10.4161/cbt.12.2.15734
Funding Information
This study was supported by KLCR grant, NIH/ NCI grants CA060872, CA105453 and CA116658 (to V.M.R.).
Repository Citation
Zhao, Yanming; Burikhanov, Ravshan; Brandon, Jason; Qiu, Shirley; Shelton, Brent J.; Spear, Brett T.; Bondada, Subbarao; Bryson, Scott; and Rangnekar, Vivek M., "Systemic Par-4 Inhibits Non-Autochthonous Tumor Growth" (2011). Radiation Medicine Faculty Publications. 14.
https://uknowledge.uky.edu/radmed_facpub/14
Notes/Citation Information
Published in Cancer Biology & Therapy, v. 12, issue 2, p. 152-157.
© 2011 Landes Bioscience